SCHEMBL7116706

SCHEMBL7116706

NC(=O)c1ccc(S(=O)(=O)NC(CCc2ccccc2)C(N)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.59
HPN P05981 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.51
MMP2 P08253 10/20 0.50
MMP9 P14780 10/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ADAMTS4 O75173 1/20 0.50
ITGB3 P05106 2/20 0.49
ITGA2B P08514 2/20 0.49
MMP7 P09237 1/20 0.49
MMP8 P22894 1/20 0.49
MMP12 P39900 1/20 0.49
MMP14 P50281 1/20 0.49
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7116600 0.87 F2 (0.59) PLAUHPNL3MBTL1MMP2MMP9
SCHEMBL7127019 0.85 PLAU (0.60) PLAUHPNL3MBTL1MMP2MMP9
SCHEMBL7130241 0.81 PLAU (0.54) PLAUHPNL3MBTL1MMP2MMP9
SCHEMBL8146180 0.79 ALDH1A1 (0.63) MMP2MMP9ALDH1A1CYP1A2CYP2C9
SCHEMBL8707457 0.79 ALDH1A1 (0.63) MMP2MMP9ALDH1A1CYP1A2CYP2C9
SCHEMBL8146178 0.79 ALDH1A1 (0.63) MMP2MMP9ALDH1A1CYP1A2CYP2C9
SCHEMBL14544528 0.78 ALDH1A1 (0.67) PLAUHPNL3MBTL1MMP2MMP9
SCHEMBL8839555 0.76 MMP2 (0.70) MMP2MMP9ALDH1A1ADAMTS4MMP7
SCHEMBL8839562 0.76 MMP2 (0.70) MMP2MMP9ALDH1A1ADAMTS4MMP7
SCHEMBL8839774 0.76 MMP2 (0.70) MMP2MMP9ADAMTS4MMP7MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO PLAU 1115/4885HPN 247/4885L3MBTL1 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.